Primary Site >> Colorectal Cancer

Gene >> PDE4A

  • 2001
  • 2007
  • 2012
  • 2013
  • 2014
  • 2016
  • 2018
Ref: Exisulind, a novel proapoptotic drug, inhibits rat urinary bladder tumorigenesis.
PMID: 11358813
Ref: Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase.
PMID: 17545604
Ref: Inhibition of phosphodiesterase-4 (PDE4) activity triggers luminal apoptosis and AKT dephosphorylation in a 3-D colonic-crypt model.
PMID: 22830422
Ref: Synthesis and biological evaluation of nimesulide based new class of triazole derivatives as potential PDE4B inhibitors against cancer cells.
PMID: 24215890
Ref: Novel quinazolin-4(3H)-one/Schiff base hybrids as antiproliferative and phosphodiesterase 4 inhibitors: design, synthesis, and docking studies.
PMID: 24985336
Ref: Resveratrol induces luminal apoptosis of human colorectal cancer HCT116 cells in three-dimensional culture.
PMID: 25075098
Ref: Phosphodiesterases in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia.
PMID: 27927168
Ref: Roflumilast, type 4 phosphodiesterase inhibitor, attenuates inflammation in rats with ulcerative colitis via down-regulation of iNOS and elevation of cAMP.
PMID: 29331766